Literature DB >> 7564511

A late-appearing Philadelphia chromosome in acute lymphoblastic leukemia confirmed by expression of BCR-ABL mRNA.

H Tsuchiya1, M Migita, S Yamamori, Y Kaneko, N Adachi, T Nakamura, Y Nobukuni, S S el-Sonbaty, I Matsuda.   

Abstract

We report two cases of acute lymphoblastic leukemia (ALL) with a late-appearing Philadelphia chromosome (Ph1), confirmed by the expression of BCR-ABL mRNA, using the reverse transcriptase/polymerase chain reaction (RT/PCR) technique. The first patient was a 10-year-old boy with precursor B cell type ALL-L1 (FAB classification). At diagnosis, no metaphase cells were found by chromosome analysis and BCR-ABL mRNA was not observed. At the beginning of relapse, which occurred after 7 months of complete remission, a normal karyotype was observed. At the terminal stage, leukemic cells with Ph1 and BCR-ABL mRNA for the P190 variety were observed. The second patient was a 12-year-old boy with immature T cell type ALL-L1. The metaphase cells showed a 9p- chromosome at diagnosis and Ph1 appeared in addition to 9p- at relapse. Hybrid mRNA for the P210 variety was detected only when Ph1 had developed. The blast cells with Ph1 were derived from the original leukemic clone through clonal evolution, since the same clonal rearrangements of IGH or TCRB were detected in leukemic cells obtained both at diagnosis and relapse in both patients. Thus, in both cases, Ph1 was detected only in the course of ALL along with expression of BCR-ABL mRNA. This observation also confirmed that, as in de novo Ph1-positive ALL, both the P190 and P210 varieties of BCR-ABL mRNA are observed in ALL with late-appearing Ph1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564511

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  2 in total

1.  Secondary Philadelphia chromosome and erythrophagocytosis in a relapsed acute myeloid leukemia after hematopoietic cell transplantation.

Authors:  Katalin Kelemen; Komal Galani; Christopher R Conley; Patricia T Greipp
Journal:  Cancer Genet       Date:  2014-06-10

2.  Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1.

Authors:  Asako Takeuchi; Toshinori Kondo; Taizo Tasaka; Seiko Yamada; Tadashi Hirose; Hirofumi Fukuda; Risa Shimizu; Yoshiko Matsuhashi; Eisei Kondo; Hideho Wada
Journal:  Leuk Res Rep       Date:  2020-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.